Khosro Keshavarz

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Systematic Review

Direct Oral Anticoagulants

Radical Prostatectomy

Juvenile Idiopathic Arthritis

Top Venues

Expert review of pharmacoeconomics & outcomes research

Hematology (Amsterdam, Netherlands)

International journal of psychiatry in clinical practice

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Goudarzi, Farhad Lotfi, Zhila Najafpour, AliAkbar Hafezi, Marzieh Alizadeh Zakaria, Khosro Keshavarz
Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran. BMC urology 24 (1) (2024)
Zahra Goudarzi, Farhad Lotfi, Zhila Najafpour, AliAkbar Hafezi, Marzieh Alizadeh Zakaria, Khosro Keshavarz
Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran. BMC urology 24 (1) (2024)
Zahra Goudarzi, Farhad Lotfi, Zhila Najafpour, AliAkbar Hafezi, Marzieh Alizadeh Zakaria, Khosro Keshavarz
Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran. BMC urology 24 (1) (2024)
Zahra Goudarzi, Farhad Lotfi, Zhila Najafpour, AliAkbar Hafezi, Marzieh Alizadeh Zakaria, Khosro Keshavarz
Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran. BMC urology 24 (1) (2024)
Farhad Lotfi, Fatemeh Khodabandeh, Abdosaleh Jafari, Mehdi Rezaee, Hamed Rahimi, Zahra Shiravani, Khosro Keshavarz
Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective. Expert review of pharmacoeconomics & outcomes research 23 (4) (2023)
Mohsen Bayati, Ahmad Gholami, Mehrnoosh Emadi, Zahra Goudarzi, Khosro Keshavarz
Pharmacies' income and its effective factors in Iran: A cross-sectional study. Health science reports 6 (6) (2023)
Farhad Lotfi, Fatemeh Khodabandeh, Abdosaleh Jafari, Mehdi Rezaee, Hamed Rahimi, Zahra Shiravani, Khosro Keshavarz
Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective. Expert review of pharmacoeconomics & outcomes research (2023)
Zahra Goudarzi, Fattaneh Danayi, Khosro Keshavarz, Ahmad Gholami
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran. Cost effectiveness and resource allocation : C/E 21 (1) (2023)
Farhad Lotfi, Fatemeh Khodabandeh, Abdosaleh Jafari, Mehdi Rezaee, Hamed Rahimi, Zahra Shiravani, Khosro Keshavarz
Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective. Expert review of pharmacoeconomics & outcomes research 23 (4) (2023)
Mohammad Faramarzi, Sara Babakhani Fard, Mohsen Bayati, Fatemeh Jafarlou, Mohammadreza Parhizgar, Mehdi Rezaee, Khosro Keshavarz
Cost-effectiveness analysis of hearing screening program for primary school children in southern Iran, Shiraz. BMC pediatrics 22 (1) (2022)
Zohreh Zahedi, Mehran Karimi, Khosro Keshavarz, Sezaneh Haghpanah, Ramin Ravangard
A cost-effectiveness analysis of the prophylaxis versus on-demand regimens in severe hemophilia A patients under 12 years old in southern Iran. Hematology (Amsterdam, Netherlands) 26 (1) (2021)
Ahmad Golami, Jassem Azizpoor, Elham Aflaki, Mehdi Rezaee, Khosro Keshavarz
Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept. BioMed research international 2021 (2021)
Neda Jaberi, Zahra Kavosi, Etrat Hooshmandi, Nasrin Moradi, Khosro Keshavarz, Afshin Borhani Haghighi
The Study of Cost-Effectiveness of Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Who Developed Ischemic Stroke. Stroke research and treatment 2021 (2021)
Khosro Keshavarz, Mohammadreza Bordbar, Zeinab Hashemipoor, Farideh Sadat Jalali, Ramin Ravangard
Economic burden of hemophilia A and B: a case in Iran. Hematology (Amsterdam, Netherlands) 25 (1) (2020)
Mohsen Ghaffari Darab, Arvin Hedayati, Elahe Khorasani, Mohsen Bayati, Khosro Keshavarz
Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews. International journal of psychiatry in clinical practice 24 (4) (2020)